SCHEMBL4862336

SCHEMBL4862336

CSc1nc(-c2ccc(S(=O)(=O)NC(=O)c3ccccc3)cc2)n(-c2ccc(C)c(C)c2)c(=O)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
HTT P42858 2/20 0.41
KMT2A Q03164 5/20 0.38
MEN1 O00255 3/20 0.38
LMNA P02545 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
KDM4E B2RXH2 2/20 0.36
USP2 O75604 2/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PTGER1 P34995 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854627 0.92 KMT2A (0.45) PTPN1HTTKMT2AMEN1LMNA
SCHEMBL4854799 0.89 PTPN1 (0.41) PTPN1HTTKMT2AMEN1LMNA
SCHEMBL4855877 0.86 PTPN1 (0.39) PTPN1LMNAL3MBTL1ALDH1A1HSD17B10
SCHEMBL4862273 0.83 ALDH1A1 (0.52) KMT2AMEN1LMNAL3MBTL1ALDH1A1
SCHEMBL4861826 0.82 HSD17B10 (0.41) PTPN1HTTKMT2AMEN1LMNA
SCHEMBL4855004 0.82 PTGS2 (0.41) PTPN1KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL4862304 0.80 PTGS2 (0.41) PTPN1KMT2AMEN1LMNAALDH1A1
SCHEMBL2949905 0.78 KDM4E (0.41) KMT2AMEN1LMNAL3MBTL1ALDH1A1
SCHEMBL4862606 0.78 PTPN1 (0.38) PTPN1KMT2AMEN1LMNAALDH1A1
SCHEMBL6141531 0.75 KMT2A (0.48) PTPN1KMT2ALMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US claimed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US claimed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP PTPN1 1393/4885HTT 960/4885KMT2A 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.